The Application of Mixed Reality to Sentinel Lymph Node Biopsy in Breast Cancer.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
15
04
2023
medline:
3
7
2023
pubmed:
7
5
2023
entrez:
6
5
2023
Statut:
ppublish
Résumé
To explore the value of mixed reality (MR) in sentinel lymph node biopsy (SLNB) in patients with breast cancer. A total of 300 patients with breast cancer who underwent SLNB enrolled and were randomly divided into two groups. In group A, only dye (an injection of methylene blue) was used to detect sentinel lymph nodes, while in group B MR was used for positioning in addition to dye. (MR localization method: Before the surgery, we built a 1:1 3D reconstruction model based on the patient's CT or MRI original data, and after the patient was injected with dye, we completed MR localization by overlapping the pre-marked image with the model.) RESULTS: During surgery, the detection time in group B was significantly shorter than in group A (3.62 ± 1.20 vs.7.87 ± 1.86; p < 0.001). At 1-month post-surgery follow-up, the incidence of pain in group B was lower than that in group A (2.70 vs. 8.28%, p = 0.036). The incidence of upper limb dysfunction was lower in group B than in group A (2.03 vs. 8.97%, p = 0.009). In terms of the incidence of pain, group B was better than group A (0.68 vs. 3.45%, p = 0.094). The satisfaction of the two groups was scored, and the results showed that group B was better than group A (4.04 ± 0.91 vs.3.32 ± 0.94, p < 0.001). The application of MR to SLNB in breast cancer can significantly reduce the detection time and the occurrence of complications and improve patient satisfaction.
Identifiants
pubmed: 37149555
doi: 10.1007/s00268-023-07028-y
pii: 10.1007/s00268-023-07028-y
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1961-1970Subventions
Organisme : he China Youth Innovation Fund of the Second Affiliated Hospital of Harbin Medical University
ID : CX2016-14
Informations de copyright
© 2023. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
Zheng Y, Wu C, Zhang M (2013) The epidemic and characteristics of female breast cancer in China. China Oncol, 561–569.
Zhang C, Xuelaiti P, Yi L et al (2017) Application and clinical analysis of methylene blue combined with the nuclide tracing method in the sentinel lymph node biopsy of early breast cancer. E-J Trans Med 4(6):29–35
Wang Y (2009) Sentinel lymph node biopsy in breast cancer: consensus and future. Chin J Bases Clin General Surg 16(7):505–509
Krag D, Anderson S, Julian T et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933
doi: 10.1016/S1470-2045(10)70207-2
pubmed: 20863759
pmcid: 3041644
Latosinsky S, Dabbs K, Moffat F et al (2008) Canadian Association of General Surgeons and American College of Surgeons Evidence Based Reviews in Surgery.27. Quality-of-life outcomes with sentinel node biopsy versus standard axillary treatment in patients with operable breast cancer. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. Can J Surg 51(6):483–485.
Veronesi U, Pagan elli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553.
Song H, Guo R (2017) Application and research progress of three-dimensional printing based on medical imaging in the diagnosis and treatment of cardiovascular diseases. Chin J Med Imag Technol 33(3):375–380
Jiang Y, Chen Y (2015) Application of 3D printing technology in foot and ankle surgery. Int J Orthopaed 52(1):15–17
Gao Q, Zhuang J, Cen J et al (2018) Application of three-dimensional printing to surgical treatment of congenital heart disease. Chin J Clin Thoracic Cardiovascular Surg 28(8):654–658
Yang H, Liao W, Sang X et al (2016) Application of 3D printing technology in medicine and hepatobiliary surgery. J Hepatobiliary Surg 24(1):66–68
Huang R, Yu J, Xie M (2016) Application and progress of 3D printing technology in foot and ankle surgery. Chin J Foot Ankle Surg 3(2):52–55
Guo B, Li T, Liu Y et al (2018) Expert consensus and technical guidelines for sentinel lymph node biopsy using the dye method in early-stage breast cancer (2018 edition). Chin J Pract Surg 38(08):855–858.
Wetzig N, Gill PG, Espinoza D, Simes J et al (2017) Sentinel-lymph-node-based management or routine axillary clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema. Ann Surg Oncol 24:1064–1070
doi: 10.1245/s10434-016-5669-2
pubmed: 27848050
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553
doi: 10.1056/NEJMoa012782
pubmed: 12904519
Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491–500
doi: 10.1245/ASO.2006.05.013
pubmed: 16514477
Gojon H, Fawunmi D, Valachis A (2014) Sentinel lymph node biopsy in patients with microinvasive breast cancer: a systematic review and meta-analysis. European journal of surgical oncology. Eur J Surg Oncol 40(1):5–11
Nagao T, Hojo T, Kurihara H et al (2014) Sentinel lymph node biopsy in patients with breast cancer with precious breast augmentation surgery. Breast Cancer 21(5):624–628
doi: 10.1007/s12282-011-0280-7
pubmed: 21671037
M Versaci, S Calcagno, FC Morabito, et al. Fuzzy geometrical approach based on unit hyper-cubes for image contrast enhancement. IEEE, New York. https://doi.org/10.1109/ICSIPA . 2015. 7412240